Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (161-170 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|February 14, 2012
Analytical characterization of ch14.18: a mouse-human chimeric disialoganglioside-specific therapeutic antibodyGopalan Soman, Abraham T Kallarakal, Dennis Michiel, et al.
Mabs|February 14, 2012
Subcutaneous bioavailability of therapeutic antibodies as a function of FcRn binding affinity in miceRong Deng, Y Gloria Meng, Kwame Hoyte, et al.
Mabs|February 14, 2012
New developments in malaria diagnostics: monoclonal antibodies against Plasmodium dihydrofolate reductase-thymidylate synthase, heme detoxification protein and glutamate rich proteinJohanna H Kattenberg, Inge Versteeg, Stephanie J Migchelsen, et al.
Mabs|November 21, 2013
Fine epitope specificity of antibodies against interleukin-2 explains their paradoxical immunomodulatory effectsGertrudis Rojas, Yanelys Cabrera Infante, Amaury Pupo, et al.
Mabs|December 20, 2019
Clinical pharmacology of vc-MMAE antibody-drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studiesChunze Li, Cindy Zhang, Zao Li, et al.
Mabs|March 7, 2020
Analytical characterization of coformulated antibodies as combination therapyJun Kim, Yoen Joo Kim, Mingyan Cao, et al.
Mabs|February 29, 2020
HX008: a humanized PD-1 blocking antibody with potent antitumor activity and superior pharmacologic propertiesJibin Zhang, Ying Huang, Gan Xi, et al.
Mabs|December 5, 2019
An engineered human IgG1 CH2 domain with decreased aggregation and nonspecific bindingGuangcan Cao, Xinyu Gao, Yancheng Zhan, et al.
Mabs|November 30, 2019
Dissecting the molecular basis of high viscosity of monospecific and bispecific IgG antibodiesCholpon Tilegenova, Saeed Izadi, Jianping Yin, et al.
Mabs|December 4, 2019
The impact of proline isomerization on antigen binding and the analytical profile of a trispecific anti-HIV antibodyAlessandro Masiero, Lechat Nelly, Gentric Marianne, et al.
Pageof 184

Showing results (161-170 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|February 14, 2012
Analytical characterization of ch14.18: a mouse-human chimeric disialoganglioside-specific therapeutic antibodyGopalan Soman, Abraham T Kallarakal, Dennis Michiel, et al.
Mabs|February 14, 2012
Subcutaneous bioavailability of therapeutic antibodies as a function of FcRn binding affinity in miceRong Deng, Y Gloria Meng, Kwame Hoyte, et al.
Mabs|February 14, 2012
New developments in malaria diagnostics: monoclonal antibodies against Plasmodium dihydrofolate reductase-thymidylate synthase, heme detoxification protein and glutamate rich proteinJohanna H Kattenberg, Inge Versteeg, Stephanie J Migchelsen, et al.
Mabs|November 21, 2013
Fine epitope specificity of antibodies against interleukin-2 explains their paradoxical immunomodulatory effectsGertrudis Rojas, Yanelys Cabrera Infante, Amaury Pupo, et al.
Mabs|December 20, 2019
Clinical pharmacology of vc-MMAE antibody-drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studiesChunze Li, Cindy Zhang, Zao Li, et al.
Mabs|March 7, 2020
Analytical characterization of coformulated antibodies as combination therapyJun Kim, Yoen Joo Kim, Mingyan Cao, et al.
Mabs|February 29, 2020
HX008: a humanized PD-1 blocking antibody with potent antitumor activity and superior pharmacologic propertiesJibin Zhang, Ying Huang, Gan Xi, et al.
Mabs|December 5, 2019
An engineered human IgG1 CH2 domain with decreased aggregation and nonspecific bindingGuangcan Cao, Xinyu Gao, Yancheng Zhan, et al.
Mabs|November 30, 2019
Dissecting the molecular basis of high viscosity of monospecific and bispecific IgG antibodiesCholpon Tilegenova, Saeed Izadi, Jianping Yin, et al.
Mabs|December 4, 2019
The impact of proline isomerization on antigen binding and the analytical profile of a trispecific anti-HIV antibodyAlessandro Masiero, Lechat Nelly, Gentric Marianne, et al.
Pageof 184